Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.4M Buy
+7,790
New +$2.42M 0.22% 172
2026
Q1
– Sell
-6,848
Closed -$1.72M – 564
2025
Q4
$1.72M Buy
+6,848
New +$1.82M 0.24% 154
2025
Q3
– Sell
-1,090
Closed -$286K – 567
2025
Q2
$286K Sell
1,090
-187
-15% -$45.5K 0.04% 420
2025
Q1
$297K Buy
+1,277
New +$310K 0.06% 360
2024
Q4
– Sell
-1,449
Closed -$324K – 484
2024
Q3
$324K Buy
+1,449
New +$318K 0.11% 319
2024
Q1
– Sell
-988
Closed -$225K – 420
2023
Q4
$225K Sell
988
-2,014
-67% -$423K 0.06% 377
2023
Q3
$604K Buy
+3,002
New +$633K 0.18% 239
2023
Q2
– Sell
-2,318
Closed -$457K – 460
2023
Q1
$457K Buy
+2,318
New +$477K 0.27% 159
2022
Q2
– Sell
-1,881
Closed -$426K – 301
2022
Q1
$426K Buy
+1,881
New +$442K 0.22% 204

Other funds holding LH

Oak Thistle's LH Position: Q3 2026 in Review

Oak Thistle opened a new position in Labcorp (LH) in Q3 2026: 7,790 shares worth $2.4M. The stake represents 0.22% of the portfolio and ranks #172 among its holdings. This is a return to the name: Oak Thistle previously reported a position in LH as recently as Q4 2025.

Oak Thistle first reported a position in LH in Q1 2022 and has held it in 9 quarters since. 925 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Oak Thistle held 7,790 shares of Labcorp worth $2.4M as of Q3 2026.
  • Labcorp was a new Oak Thistle position in Q3 2026.
  • Labcorp made up 0.22% of Oak Thistle's portfolio in Q3 2026, its #172 holding.
  • Oak Thistle first reported a position in Labcorp in Q1 2022 and has held it in 9 quarters since.
  • 925 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Oak Thistle's 13F filing for Q3 2026, filed 21 Oct 2026.